Healthcare Small Cap Stocks
Healthcare, medical devices, and health IT small caps — companies innovating in diagnostics, treatment delivery, and healthcare administration at compelling valuations.
| Ticker | Company | Price | Mkt Cap | P/E | Rev. Growth | Upside |
|---|---|---|---|---|---|---|
| VIAV | Viavi Solutions | $42.42 +1.82% | $10.46B | — | 42.8% | 52.2% |
| ENSG | Ensign Group | $166.83 -0.83% | $9.75B | 27.2x | 18.4% | 32.1% |
| TVTX | Travere Therapeutics | $57.48 +0.98% | $5.35B | — | 55.6% | 1.5% |
| STVN | Stevanato Group | $19.37 +1.93% | $5.29B | 33.4x | 6.6% | 26.2% |
| ALHC | Alignment Healthcare | $24.56 +3.19% | $5.08B | 245.6x | 33.3% | 1.5% |
| NVST | Envista Holdings | $27.51 -0.43% | $4.48B | 67.1x | 14.4% | 7.9% |
| MMSI | Merit Medical Systems | $71.45 +0.51% | $4.26B | 30.8x | 7.5% | 25.3% |
| IRTC | iRhythm Technologies | $126.03 -0.36% | $4.14B | — | 25.7% | 42% |
| CLDX | Celldex Therapeutics | $37.95 -1.09% | $2.98B | — | -97.8% | 51.6% |
| LMAT | LeMaitre Vascular | $103.72 +0.82% | $2.37B | 38.1x | 11.2% | 14.5% |
| AGIO | Agios Pharmaceuticals | $37.39 -0.51% | $2.22B | — | 137.7% | 9% |
| ADMA | ADMA Biologics | $9.16 +2.35% | $2.12B | 13.5x | 15.9% | 92.1% |
| OMCL | Omnicell | $45.24 +5.14% | $2.06B | 102.8x | 14.9% | 35.5% |
| NVCR | NovoCure | $17.32 +0.7% | $2.01B | — | 12.3% | 50.1% |
| ATEC | Alphatec Holdings | $9.33 +4.6% | $1.43B | — | 13.6% | 79.3% |
| USPH | US Physical Therapy | $73.38 +1.42% | $1.12B | 146.8x | 7.9% | 27.7% |
| XNCR | Xencor | $14.89 -0.73% | $1.1B | — | -86.2% | 91.4% |
| CNMD | Conmed Corporation | $35.11 +3.78% | $1.06B | 19.8x | -1.3% | 12.8% |
| TNDM | Tandem Diabetes Care | $15.42 +0.65% | $1.06B | — | 5.5% | 87.3% |
| HSTM | HealthStream | $29.07 +2.32% | $849.3M | 43.4x | 10.5% | 10.1% |
| INMD | InMode | $14.60 -1.35% | $839.2M | 10.8x | 5.3% | -1.8% |
| EOLS | Evolent Health | $6.99 +1.3% | $460.3M | — | 6.7% | 109.8% |
| TMCI | Treace Medical Concepts | $4.56 +8.31% | $295.8M | — | -10.2% | -12.3% |
| EMBC | Embecta Corp | $3.28 -2.09% | $194.6M | 1.7x | -14.4% | 22% |
| AMWL | Amwell | $9.29 +0.43% | $155.2M | — | -17.9% | -19.3% |
| TELA | Tela Bio | $0.79 +9% | $35.2M | — | 2.9% | 186.2% |
| CTSO | Cytosorbents Corporation | $0.43 +10.26% | $27M | — | 1.6% | 568.6% |
Analysis and Context
This sector screener currently shows 27 stocks from the selected industry segment — updated daily. The average P/E ratio is 60.1x. The average revenue growth rate is 8.2%. Sectors move through cyclical phases strongly correlated with macro factors — interest rates, GDP growth, commodity prices, and regulatory environment all drive sector dynamics. Analysts see an average of 59.4% upside in these sector names. Compare metrics against the sector average to identify relative over- and undervaluations. Sector concentration increases portfolio risk — maintain adequate diversification across industries and business models.
Ready to invest?
Compare the best brokers for US and European stocks — fees, platforms and account types side by side.
Compare brokers →